Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice.

Pandey M, Calcutt A, Ozberk V, Chen Z, Croxen M, Powell J, Langshaw E, Mills JL, Jen FE, McCluskey J, Robson J, Tyrrell GJ, Good MF.

Sci Adv. 2019 Sep 4;5(9):eaax3013. doi: 10.1126/sciadv.aax3013. eCollection 2019 Sep.

2.

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy.

Pandey M, Ozberk V, Langshaw EL, Calcutt A, Powell J, Batzloff MR, Rivera-Hernandez T, Good MF.

NPJ Vaccines. 2018 Apr 26;3:15. doi: 10.1038/s41541-018-0053-9. eCollection 2018.

3.

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial.

Pandey M, Powell J, Calcutt A, Zaman M, Phillips ZN, Ho MF, Batzloff MR, Good MF.

Sci Rep. 2017 Oct 23;7(1):13786. doi: 10.1038/s41598-017-14157-7.

4.

Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen.

Nordström T, Pandey M, Calcutt A, Powell J, Phillips ZN, Yeung G, Giddam AK, Shi Y, Haselhorst T, von Itzstein M, Batzloff MR, Good MF.

J Immunol. 2017 Oct 15;199(8):2794-2802. doi: 10.4049/jimmunol.1700836. Epub 2017 Sep 13.

5.

Descriptive analysis of a 1:1 physiotherapy outpatient intervention post primary lumbar discectomy: one arm of a small-scale parallel randomised controlled trial across two UK sites.

Rushton A, Calcutt A, Heneghan N, Heap A, White L, Calvert M, Goodwin P.

BMJ Open. 2016 Nov 9;6(11):e012151. doi: 10.1136/bmjopen-2016-012151.

6.

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma.

Pandey M, Ozberk V, Calcutt A, Langshaw E, Powell J, Rivera-Hernandez T, Ho MF, Philips Z, Batzloff MR, Good MF.

PLoS Pathog. 2016 Dec 27;12(12):e1006122. doi: 10.1371/journal.ppat.1006122. eCollection 2016 Dec.

7.

Novel platform technology for modular mucosal vaccine that protects against streptococcus.

Zaman M, Ozberk V, Langshaw EL, McPhun V, Powell JL, Phillips ZN, Ho MF, Calcutt A, Batzloff MR, Toth I, Hill GR, Pandey M, Good MF.

Sci Rep. 2016 Dec 15;6:39274. doi: 10.1038/srep39274.

8.

Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.

Batzloff MR, Fane A, Gorton D, Pandey M, Rivera-Hernandez T, Calcutt A, Yeung G, Hartas J, Johnson L, Rush CM, McCarthy J, Ketheesan N, Good MF.

Hum Vaccin Immunother. 2016 Dec;12(12):3089-3096. doi: 10.1080/21645515.2016.1222999. Epub 2016 Aug 19.

9.

Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.

Pandey M, Mortensen R, Calcutt A, Powell J, Batzloff MR, Dietrich J, Good MF.

J Immunol. 2016 Apr 15;196(8):3364-74. doi: 10.4049/jimmunol.1501994. Epub 2016 Mar 11.

10.

Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes.

Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG.

Am Surg. 1999 Jan;65(1):22-6.

PMID:
9915526
11.

A population of cells resident within embryonic and newborn rat skeletal muscle is capable of differentiating into multiple mesodermal phenotypes.

Lucas PA, Calcutt AF, Southerland SS, Alan Wilson J, Harvey RL, Warejcka D, Young HE.

Wound Repair Regen. 1995 Oct-Dec;3(4):449-60.

PMID:
17147656

Supplemental Content

Loading ...
Support Center